Childhood onset of Crohn disease: Experience from a university teaching hospital in Saudi Arabia

Annals of Saudi Medicine

Volumn 32, Issue 6, 2012, Pages 596-602

  Saadah, Omar I ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BARIUM; C REACTIVE PROTEIN; CONTRAST MEDIUM; ENEMA; INFLIXIMAB; MESALAZINE; PREDNISOLONE;

ABDOMINAL PAIN; ADOLESCENT; ANEMIA; ANOREXIA; ANUS DISEASE; ARTICLE; BARIUM MEAL; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COLON DISEASE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; CROHN DISEASE; DIARRHEA; DRUG DOSE REDUCTION; ENTERIC FEEDING; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HYPOALBUMINEMIA; ILEUM DISEASE; INFANT; INTESTINE SURGERY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RELATIVE; REMISSION; RETROSPECTIVE STUDY; SAUDI ARABIA; SCHOOL CHILD; SHORT STATURE; TENESMUS; THROMBOCYTE COUNT; THROMBOCYTOSIS; UNDERWEIGHT; UNIVERSITY HOSPITAL; UPPER GASTROINTESTINAL TRACT; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MORBIDITY; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA;

EID: 84873932241     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2012.596     Document Type: Article

References (39)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12 Suppl 1:S3-S9.
2. Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: Guidelines for the adult and pediatric gastroenterologist. Inflamm Bowel Dis. 2010;17:2169-73.
3. Abramson O, Durant M, Mow W, Finley A, Kodali P, Wong A, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr. 2010;157:233-9 e1.
4. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis-a population-based study from the Danish Crohn Colitis Database. Eur J Gastroenterol Hepatol. 2009;21:1291-301.
5. Kirsner JB, Shorter RG. Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med. 1982;306:837-48.
6. Mokhtar A, Khan, M.A. Crohn's Disease in Saudi Arabians. Saudi Med J. 1982;3:270-4.
7. Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, Aljebreen AM, Isnani AC, et al. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World J Gastroenterol. 2004;10:1341-4.
8. Al-Gindan YM, Satti MB, Al-Quorain AA, Al-Hamdan A. Crohn's disease in Saudi Arabia: a clinicopathological study of 12 cases. Saudi J Gastroenterol. 1996;2:150-5.
9. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:2-15.
10. Toonisi TS. Crohn's disease in children from the western region of Saudi Arabia. J Gastroenterol Hepatol. 1993;8:462-4.
11. El Mouzan MI, Abdullah AM, Al Habbal MT. Epidemiology of juvenile-onset inflammatory bowel disease in central Saudi Arabia. J Trop Pediatr. 2006;52:69-71.
12. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis- the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
13. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5-36.
14. Hofley PM, Piccoli DA. Inflammatory bowel disease in children. Med Clin North Am. 1994;78:1281-302.
15. Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35-40.
16. Ruemmele FM, El Khoury MG, Talbotec C, Maurage C, Mougenot JF, Schmitz J, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603-9.
17. Pashankar D, Schreiber RA, Israel DM. Perianal Crohn's disease in infancy. J Pediatr Gastroenterol Nutr. 2000;31:80-2.
18. El-Mouzan MI, Al-Salloum AA, Al-Herbish AS, Qurachi MM, Al-Omar AA. Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi Med J. 2007;28:1881-4.
19. Roma ES, Panayiotou J, Pachoula J, Constantinidou C, Polyzos A, Zellos A, et al. Inflammatory bowel disease in children: the role of a positive family history. Eur J Gastroenterol Hepatol. 2010;22:710-5.
20. Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63-8.
21. Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis. 2010;16:332-7.
22. Lisciandrano D, Ranzi T, Carrassi A, Sardella A, Campanini MC, Velio P, et al. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol. 1996;91:7-10.
23. Asquith P, Thompson RA, Cooke WT. Oral manifestations of Crohn's disease. Gut. 1975;16:249-54.
24. Irvine GH, Fisher C. Crohn's disease of the tongue. J R Coll Surg Edinb. 1982;27:269-70.
25. Rogers RS, 3rd. Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin. 1996;14:371-9.
26. Nemeth A, Ejderhamn J, Glaumann H, Strandvik B. Liver damage in juvenile inflammatory bowel disease. Liver. 1990;10:239-48.
27. Hyams J. MJ, Treem W, Davis P, Grancher K, Daum F. Characterization of Hepatic Abnormalities in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis. 1995;1:27-33.
28. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 2003;52:552-7.
29. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-50.
30. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001; 49:777-82.
31. Nos P, Hinojosa J, Mora J, Garrigues V, Ponce J. Validation of a simplified clinical index to predict evolving patterns in Crohn's disease. Eur J Gastroenterol Hepatol. 2002; 14: 847-51.
32. Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis. 2004;10:521-8.
33. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of phenotypic characteristics of childhoodonset inflammatory bowel disease. Gastroenterology. 2008;135:1114-22.
34. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8-15.
35. Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006;4:744-53.
36. Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000;14:281-9.
37. Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007;132:863-73.
38. Brigham GS, Feaster DJ, Wakim PG, Dempsey CL. Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat. 2009;37:388-97.
39. Viola F, Civitelli F, Di Nardo G, Barbato MB, Borrelli O, Oliva S, et al. Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease. Am J Gastroenterol. 2009;104:2566-71.